Columnists
How Invion plans to use light therapy to treat ovarian cancer
Columnists
Painchek is in a world of pain – and that’s a very good thing
Columnists
What’s next for five-bagger Patrys on journey across the blood-brain barrier
Columnists
Why Medlab has a head start among cannabis stocks
Columnists
Will investors go weak at the knees for Orthocell’s new tendon treatment?
Columnists
Avita is a slow burn for investors as spray-on skin approaches US debut
Columnists
The ASX’s only gene therapist Benitec is undergoing clinical trials this year
Columnists